More importantly, it was effective in preventing the migration of MUC-1 cells, representing the most aggressive available ACC cell model, characterized by the resistance to mitotane and to a wide range of therapeutics [24] and with a high metastatic potential [25]. Here, MUC1 is linked to adrenal cortex carcinoma.